G-TOG Collaborative Group

G-TOG (German Thoracic Oncology Group) is a specialized clinical research organization and collaborative network dedicated to advancing the treatment of lung cancer and other thoracic malignancies. Based in Germany, the group designs and executes multicenter clinical trials, ranging from Phase 2 to Phase 3, often in partnership with leading academic centers and pharmaceutical companies. Their research portfolio focuses on optimizing therapeutic strategies, including the integration of immunotherapies and targeted agents into standard care. G-TOG serves as a critical bridge between clinical research and practical application in oncology, aiming to improve survival rates and quality of life for patients. The organization operates as a registered association, facilitating high-quality investigator-initiated trials (IITs) across a broad network of German clinics.